SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is experiencing significant momentum following recent international regulatory approvals for its Anktiva treatment and compelling updates from ongoing clinical trials, fueling widespread community optimism. The stock is seeing massive trading volume and a strong belief in an intensifying short squeeze, with many retail investors expressing conviction in the company's long-term potential to revolutionize cancer treatment.

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Venus Concept Inc

Venus Concept (VERO) is trending following Madryn Asset Management's acquisition of a 91% stake, sparking widespread discussion about potential privatization or delisting to reduce operational costs. The community is sharply divided, with bulls anticipating a significant short squeeze fueled by the now extremely low public float. Conversely, skeptics caution against a "pump and dump" scenario and potential dilution or a lower buyout price as the company's long-term financials are scrutinized.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Platforms is trending due to a landmark multi-year data center lease with Advanced Micro Devices, signaling a significant strategic pivot towards high-performance computing and AI infrastructure. This transformative deal is generating immense bullish sentiment within the community, validating Riot's strategic shift from Bitcoin mining and fueling expectations for further substantial partnerships.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending due to significant selling pressure, with the community attributing much of the decline to ongoing insider share sales and impending lock-up expirations, leading to widespread investor frustration over post-IPO losses. However, amidst the bearish sentiment, some investors are buying dips, highlighting Figma's strong adoption as a core design tool, its market leadership, and strategic AI integrations as reasons for long-term confidence despite current market dynamics.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending due to multiple analyst downgrades and heightened concerns over AI-driven competition, including new offerings from Apple, impacting the broader software sector. While many express fear that AI will significantly disrupt Adobe's established creative suite and subscription model, others view the stock as deeply oversold given its strong fundamentals, consistent growth, and historically low valuation, anticipating a rebound as AI integration evolves.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is trending as its investor day revealed significantly raised 2026 revenue guidance and a surging backlog, reinforcing bullish outlooks for its autonomous defense and security solutions. Despite mixed community reactions to the presentation's delivery and short-term price fluctuations, investors are keenly focused on the company's strategic growth in the drone sector and the substantial capital raised, which many view as a strong long-term indicator.

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. It operates through the Biotechnology and Technology segments. The Biotechnology segment is involved in developing biotechnology product pipelines. The Technology segment relates to acquiring technology assets to support and enhance operational capabilities through advanced technologies. The company was founded in 2017 and is headquartered in Wexford, PA.

Coeptis Therapeutics Holdings Inc

Coeptis Therapeutics Inc

Coeptis Therapeutics is trending amidst widespread anticipation for its imminent merger with Z Squared, a Dogecoin and Litecoin mining company, with a crucial shareholder vote approaching. The community is actively discussing the potential for a substantial revaluation and a significant upside, as the company pivots from biotech to digital asset mining with its value increasingly linked to crypto performance. Many are watching for a potential short squeeze, despite recent low trading volume attributed to short interest.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian ($TEAM) is at the center of a heated community debate following a significant price decline, fueled by concerns that AI advancements could render its collaborative software obsolete. While many fear further drops and note ongoing insider selling, others argue the sell-off is an overreaction and unjustified capitulation across the broader software sector, presenting a compelling buying opportunity given the company's strong fundamentals and oversold technicals.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

ARS Pharmaceuticals (SPRY) is trending as its competitor, AQST, received an FDA deficiency letter, potentially solidifying Neffy's lead in the needle-free epinephrine market. The community is actively discussing a significant short squeeze opportunity for SPRY, fueled by high short interest and recent global approvals, alongside its promising pipeline expansion into new indications like urticaria treatment.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is drawing significant attention following the announcement of a new 200 million share buyback program and substantial European defense procurements, including Leopard 2 tanks powered by its MTU engines. The community expresses strong bullish sentiment, anticipating robust upcoming earnings and the game-changing potential of its Small Modular Reactor (SMR) technology.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ARS Pharmaceuticals (NASDAQ:SPRY) Shares Down 12.3% - Should You Sell?

ARS Pharmaceuticals (NASDAQ:SPRY) Shares Down 12.3% - Time to Sell...

SPRY Makes Bullish Cross Above Critical Moving Average

In trading on Friday, shares of ARS Pharmaceuticals Inc (Symbol: SPRY) crossed above their 200 day moving average of $12.77, changing hands as high as $13.01 per share. ARS Pharmaceuticals Inc shares...

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the eight analysts that are currently covering the company...

ARS Pharmaceuticals (NASDAQ:SPRY) Shares Up 3.4% - Time to Buy?

ARS Pharmaceuticals (NASDAQ:SPRY) Trading 3.4% Higher - Here's Why...

ARS Pharmaceuticals (NASDAQ:SPRY) Trading 7.9% Higher - What's Next?

ARS Pharmaceuticals (NASDAQ:SPRY) Shares Up 7.9% - Should You Buy...

ARS Pharmaceuticals (NASDAQ:SPRY) Stock Price Up 6.3% - Time to Buy?

ARS Pharmaceuticals (NASDAQ:SPRY) Trading 6.3% Higher - What's Next...

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Receives Consensus Rating of "Moderate Buy" from Analysts

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eight ratings firms that are presently covering the stock...

ARS Pharmaceuticals (NASDAQ:SPRY) Shares Up 8.1% - Here's What Happened

ARS Pharmaceuticals (NASDAQ:SPRY) Stock Price Up 8.1% - What's Next...

Franklin Resources Inc. Sells 28,789 Shares of ARS Pharmaceuticals, Inc. $SPRY

Franklin Resources Inc. trimmed its stake in shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Free Report) by 1.5% during the second quarter, according to the company in its most recent disclosure...

ARS Pharmaceuticals (NASDAQ:SPRY) Raised to Hold at Zacks Research

Zacks Research upgraded shares of ARS Pharmaceuticals from a "strong sell" rating to a "hold" rating in a research report on Thursday...

Traders are discussing the unwinding of a popular pairs trade involving its key competitor, particularly after recent adverse FDA news for that rival.

Significant short interest, cited at 20.5-21%, is sparking conversations about a potential imminent short squeeze for the stock.

SPRY
ARS Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SPRY News

SPRYARS Pharmaceuticals Inc